SGEM XTRA - By admin - May 1, 2021
..."We think a lot of people out there find this topic very frustrating. It has been more than 25 years, and we are still repeating the same debate over and over again. There are two sides of this – the research side and the clinical side. This topic won’t be settled until we get follow up RCTs. We agree with Donaldson’s conclusions that further RCTs are urgently needed.
Clinically speaking, we think some people get so frustrated that they just tune out. But this discussion about how to clinically apply the evidence is really important. The reason we show up to work every day is our patients. Unfortunately, at this point in time there isn’t a clear answer. However, our patients deserve to know about the evidence for thrombolytics for acute ischemic strokes."